Jul. 13 at 12:03 PM
$POM POMDOCTOR LIMITED Regains Compliance with Nasdaq Bid Price Requirement
PR Newswire
GUANGZHOU, China, July 13, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ: POM), a digital healthcare company focused on advancing AI-enabled healthcare solutions and predictive healthcare capabilities, today announced that on July 10, 2026, the Company received a letter (the "Compliance Letter") from The Nasdaq Stock Market LLC ("Nasdaq") informing the Company that it has regained compliance with the minimum bid price requirement of
$1.00 per share under Nasdaq Listing Rule 5450(a)(1). As a result, the matter has been closed.
As previously disclosed, on January 29, 2026, the Company received a notification letter from Nasdaq indicating that the closing bid price of the Company's American Depositary Shares had been below
$1.00 per share for 30 consecutive business days. Nasdaq has since determined that, for the last 10 consecutive business days, ....